Acute pancreatitis, which include deadly and non-fatal hemorrhagic or necrotizing pancreatitis, has long been noticed in patients dealt with with GLP-one receptor agonists. Pancreatitis has long been described in Mounjaro clinical trials. Mounjaro has not been studied in clients with a prior background of pancreatitis. Make contact with your U.S. https://docs.google.com/document/d/1bSE0RrndKmZ6FYu0PotYIXkNFnWcw7rtv4s8CcblqWU/edit?usp=sharing